Hepatitis D screening: Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:


==Screening==
==Screening==
All
All patients with current or previous IV drug use history should be evaluated for hepatitis B. However, screening is not recommended in asymptomatic HBsAg positive patients 


<!--
<!--
Drug treatment programs should screen all patients for immunity to hepatitis B. Routine screening for hepatitis D is not indicated in persons who are HBsAg positive but asymptomatic. However, the following screening and prevention procedures may be appropriate:  
. However, the following screening and prevention procedures may be appropriate:  
* Patients known to be HBsAg positive who have acute or chronic hepatitis may be tested for hepatitis D. The followup care and counseling, however, of a person co-infected with hepatitis D is not different from that of a person who is HBsAg positive. Therefore, knowing if the patient is co-infected with hepatitis D is of limited clinical significance.
* Patients known to be HBsAg positive who have acute or chronic hepatitis may be tested for hepatitis D. The followup care and counseling, however, of a person co-infected with hepatitis D is not different from that of a person who is HBsAg positive. Therefore, knowing if the patient is co-infected with hepatitis D is of limited clinical significance.



Revision as of 02:54, 6 August 2014